 Despite the disappointing outcome of the vaccine supply agreement with Novavax, FUJIFILM has printed strong Q1-2 FY32023 results and raised FY guidance. The companys strategic focus on growing its medical and semiconductor-related businesses looks positive for longer-term earnings visibility. 